Evidence map›Paper›PMID 41875231›Full record

ArticleScience signaling2026

Location-biased β-arrestin conformations direct GPCR signaling.

Uyen Pham, Anand Chundi, Tomasz M Stępniewski, Srikrishna Darbha, Dylan S Eiger, Sonia Gazula, Julia Gardner, Chloe Hicks, Jana Selent, Sudarshan Rajagopal

Abstract read
In one paragraph

Article in Science signaling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. CXCR1 and CXCR2 display receptor bias for shared chemokine agonists.bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Uyen PhamDepartment of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-2038-6794
Anand ChundiDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0001-8148-7479
Tomasz M StępniewskiResearch Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences of Pompeu Fabra University (UPF)-Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.ORCID 0000-0002-6828-9192
Srikrishna DarbhaTrinity College, Duke University, Durham, NC 27710, USA.ORCID 0009-0001-0453-5972
Dylan S EigerDepartment of Medicine, Brigham and Women's Hospital, Boston, MA 02215, USA.ORCID 0000-0001-9572-6282
Sonia GazulaPenn Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Julia GardnerPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-1581-5048
Chloe HicksYale University School of Medicine, New Haven, CT 06510, USA.ORCID 0000-0001-6728-7737
Jana SelentResearch Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences of Pompeu Fabra University (UPF)-Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.ORCID 0000-0002-1844-4449
Sudarshan RajagopalDepartment of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-3443-5040

Funding

Biasing CXCR3 Signaling to Modulate the Inflammatory ResponseR01GM122798 · NIGMS · DUKE UNIVERSITY · PI RAJAGOPAL, SUDARSHAN · 2017 to 2025
$3.2M
NIGMS NIH HHS R01 GM122798
6 · The paper itself

Abstract

β-Arrestins are multifunctional, intracellular proteins that regulate the desensitization, internalization, and signaling of more than 800 G protein-coupled receptors (GPCRs) and interact with a diverse array of intracellular partners. Beyond the plasma membrane, GPCRs can initiate distinct signaling cascades from various subcellular locations, a phenomenon known as "location bias." Here, we investigated how β-arrestins directed location-biased signaling of the angiotensin II type 1 receptor (AT1R) using bioluminescence resonance energy transfer (BRET) conformational biosensors and extracellular signal-regulated kinase (ERK) activity reporters. We found that, in response to the endogenous agonist angiotensin II and the β-arrestin-biased agonist TRV023, β-arrestin 1 and β-arrestin 2 adopted distinct conformations across different subcellular locations, which were associated with different ERK activation profiles. We also uncovered a population of receptor-free, activated β-arrestins in the plasma membrane that exhibited insensitivity to different agonists and promoted ERK activation at the plasma membrane independently of G proteins. These findings deepen our understanding of GPCR signaling complexity and highlight the nuanced roles of β-arrestins beyond traditional G protein pathways.

Indexed as

beta-Arrestin 1beta-Arrestin 2beta-ArrestinsReceptor, Angiotensin, Type 1Receptors, G-Protein-CoupledSignal TransductionAngiotensin IIAnimalsBioluminescence Resonance Energy Transfer TechniquesCell MembraneExtracellular Signal-Regulated MAP KinasesHEK293 CellsHumansProtein ConformationAngiotensin IIbeta-Arrestin 1beta-Arrestin 2beta-ArrestinsExtracellular Signal-Regulated MAP KinasesReceptor, Angiotensin, Type 1Receptors, G-Protein-Coupled

Identifiers

PMID41875231
PMCPMC13653761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.